M&A Deal Summary

Magnum Capital Industrial Partners Acquires GENERIS Farmacêutica S.A.

On January 26, 2009, private equity firm Magnum Capital Industrial Partners acquired life science company GENERIS Farmacêutica S.A. for 200M EUR

Acquisition Highlights
  • This is Magnum Capital Industrial Partners’ 1st transaction in the Life Science sector.
  • This is Magnum Capital Industrial Partners’ largest (disclosed) transaction.
  • This is Magnum Capital Industrial Partners’ 3rd transaction in Portugal.
Investment Fate
  • GENERIS Farmacêutica S.A. was sold to a publicly-traded strategic buyer in 2017 for 135M .
  • GENERIS Farmacêutica S.A. was sold to a strategic buyer in 2017 for 135M EUR.

M&A Deal Summary
Date 2009-01-26
Target GENERIS Farmacêutica S.A.
Sector Life Science
Buyer(s) Magnum Capital Industrial Partners
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 200M EUR

Target

GENERIS Farmacêutica S.A.

Amadora, Portugal
GENERIS® Farmacêutica, S.A. is a drug development, contract manufacturing and licensing-out company specialized in the manufacturing of solid oral dosage forms.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Magnum Capital Industrial Partners

Madrid, Spain

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2006
PE ASSETS 1.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Magnum Capital is a private equity firm focused on investing in upper middle-market companies located in Spain and Portugal. Magnum prefers control investments in the industrial and service sectors. The Firm's target investment size is €30 to €100 million in businesses valued from €150 to €800 million. Prospective investment situations include family-owned companies with potential for 'increased operating efficiencies', corporate spin-offs, shareholder liquidity needs, and Iberian companies looking to expand beyond the local area. Magnum Capital was formed in 2006 and has offices in Madrid and Lisbon.

DEAL STATS #
Overall 5 of 24
Sector (Life Science) 1 of 2
Type (Buyout (LBO, MBO, MBI)) 4 of 15
Country (Portugal) 3 of 4
Year (2009) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-11-16 Iberwind - Desenvolvimento e Projectos S.A.

Algés, Portugal

Iberwind - Desenvolvimento e Projectos S.A. is a Portuguese renewable energy wind company. Iberwind engages in electrical power generation through wing energy with with 524 Mega Watt under operation. The company is based in Portugal.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-16 Centro Médico Teknon S.L.

Barcelona, Spain

Centro Médico Teknon S.L. is a private acute care hospitals.

Buy €140M
Mergr

Product

Company

Legal